아나필락시스 치료 시장 보고서(2025년)

Anaphylaxis treatment involves addressing life-threatening allergic reactions to allergens such as foods, insect stings, medications, and latex. Immediate administration of epinephrine is crucial to counteract the allergic response and stabilize the patient's condition. Effective management of anaphylaxis requires rapid medical intervention and comprehensive supportive care to alleviate potentially life-threatening symptoms.

Key treatments for anaphylaxis include epinephrine, antihistamines, steroids, beta-antagonists, and other supportive measures. Epinephrine, a synthetic or extracted form of adrenaline, is the primary and essential therapy for anaphylaxis. It must be administered promptly upon identifying the condition to prevent the onset of severe symptoms. These treatments are available in various forms such as tablets and capsules and are distributed through hospital pharmacies, retail pharmacies, and online platforms, addressing allergies such as food allergies, pollen allergies, dust mite allergies, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The anaphylaxis treatment market research report is one of a series of new reports from The Business Research Company that provides anaphylaxis treatment market statistics, including anaphylaxis treatment industry global market size, regional shares, competitors with an anaphylaxis treatment market share, detailed anaphylaxis treatment market segments, market trends and opportunities, and any further data you may need to thrive in the anaphylaxis treatment industry. This anaphylaxis treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The anaphylaxis treatment market size has grown strongly in recent years. It will grow from $6.19 billion in 2024 to $6.59 billion in 2025 at a compound annual growth rate (CAGR) of 6.5%. The growth in the historic period can be attributed to increasing incidence of allergic reactions, wider recognition of anaphylaxis, increased availability of epinephrine auto-injectors, public awareness and education, healthcare professional training.

The anaphylaxis treatment market size is expected to see strong growth in the next few years. It will grow to $8.68 billion in 2029 at a compound annual growth rate (CAGR) of 7.1%. The growth in the forecast period can be attributed to innovation in biologic therapies, customized treatment approaches, global efforts on food safety, patient empowerment and advocacy, enhanced emergency medical services. Major trends in the forecast period include auto-injectors innovation, telemedicine for anaphylaxis management, improved allergen immunotherapy, biometric wearables for allergen detection, collaborations in allergy research.

The forecast of 7.1% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff escalations are likely to burden U.S. allergy patients by driving up the cost of prefilled epinephrine syringes and emergency airway devices sourced from Germany and Denmark, exacerbating out-of-pocket costs for life-saving interventions. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The rising prevalence of food allergies is expected to drive the growth of the anaphylaxis treatment market. Food allergy refers to an immune response triggered by proteins in food. Anaphylaxis treatment is crucial in preventing the progression of life-threatening allergic reactions that affect the skin, mucosal surfaces, respiratory function, blood pressure, and vital organs. For instance, in January 2023, the Centers for Disease Control and Prevention (CDC), a US-based government agency, reported that in 2021, 31.8% of adults aged 18 and older experienced eczema, a seasonal allergy, or a food allergy. Among these, 25.7% had a seasonal allergy, 6.2% had a food allergy, and 7.3% had eczema. Additionally, in August 2024, the Food Standards Agency, a UK-based non-ministerial department, revealed that 296 valid case reports were submitted to the Registry between October 2021 and August 27, 2023. These reports likely reflect less than 5% of accidental reactions in the UK, with 213 (72%) attributed to food triggers and 208 (97.7%) occurring in individuals aged 18 or younger, with only 28 clinics and 11 Accident & Emergency (A&E) departments registered for access to the platform. Thus, the increasing prevalence of food allergies is driving the growth of the anaphylaxis treatment market.

The growth of the anaphylaxis treatment market is also expected to be driven by rising healthcare expenditure. Healthcare expenditure refers to the total spending on healthcare goods and services over a specific period, typically at the national level or within a healthcare system. Increased healthcare spending improves access to anaphylaxis treatment options, ensuring timely availability of life-saving medications, fostering research and development efforts, creating alternative treatment options, improving emergency response systems, and implementing preventive measures. For example, in September 2024, the Centers for Medicare and Medicaid Services (CMS), a US-based federal agency, reported that US healthcare expenditure grew by 4.1% in 2022, reaching $4.5 trillion, equivalent to $13,493 per person and representing 17.3% of the nation's gross domestic product. Therefore, the increase in healthcare expenditure is contributing to the growth of the anaphylaxis treatment market.

Advancements in product development mark a significant trend in the anaphylaxis treatment market. Major industry players are intensifying their product innovations to maintain a competitive edge. For example, in April 2022, Aquestive Therapeutics Inc., a US-based pharmaceutical firm, secured Fast Track designation from the Food and Drug Administration for AQST-109, an orally administered epinephrine product candidate designed for treating severe allergic responses, including anaphylaxis. This pioneering solution is a notable milestone, showing comparable clinical outcomes to autoinjectors such as EpiPen and Auvi-Q in managing allergic emergencies.

Companies at the forefront of the anaphylaxis treatment market are prioritizing innovative solutions such as the sulfite-free epinephrine injection to drive market growth. This injection, a crucial life-saving medication for severe allergic reactions, has witnessed advancements in its formulations. For instance, in March 2023, American Regent Inc., a leading US-based pharmaceutical company, launched a sulfite-free epinephrine injection USP. This product, suitable for subcutaneous, intramuscular, and intravenous administration, boasts a formulation devoid of sulfites or preservatives. Notably, it's recommended for adult patients experiencing hypotension due to septic shock to elevate mean arterial blood pressure.

In October 2023, the US-based biopharmaceutical company Amgen Inc. completed the acquisition of Horizon Therapeutics Plc for a substantial sum of $27.8 billion. This strategic move positions Amgen to expand its product portfolio, enabling the company to provide treatments for severe inflammatory, autoimmune, and rare disorders. The acquisition underscores Amgen's commitment to leveraging biotechnology to address the healthcare needs of patients facing life-threatening conditions. Horizon Therapeutics PLC, based in Ireland, is a biopharmaceutical company with a focus on developing innovative therapeutic solutions.

Major companies operating in the anaphylaxis treatment market include Merck & Co. Inc., Novartis International AG, GlaxoSmithKline plc, Viatris Inc., Teva Pharmaceutical Industries Ltd., Mylan N.V., Bausch Health Companies, Sun Pharmaceutical Industries Ltd., Perrigo Co, Dr. Reddy's Laboratories Ltd., Hikma Pharmaceuticals plc, Amneal Pharmaceuticals Inc., ALK-Abello A/S, Amphastar Pharmaceuticals Inc., Par Pharmaceutical Inc., Genentech Inc., Meridian Medical Technologies LLC, Aquestive Therapeutics Inc., Sandoz Inc., Adamis Pharmaceutical Corporation, Impax Laboratories LLC

North America was the largest region in the anaphylaxis treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the anaphylaxis treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the anaphylaxis treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The anaphylaxis treatment market consists of sales of bronchodilators, corticosteroids, and vasopressors. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Anaphylaxis Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on anaphylaxis treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for anaphylaxis treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The anaphylaxis treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Treatment: Epinephrine; Antihistamines; Steroids; Beta-antagonists; Other Treatments
• 2) By Product: Tablets; Capsules; Other Products
• 3) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy; Online Pharmacy
• 4) By Application: Food Allergy; Pollen Allergy; Dust Mites Allergy; Other Applications
• Subsegments:
• 1) By Epinephrine: Auto-Injectors; Vials Or Syringes
• 2) By Antihistamines: Oral Antihistamines; Injectable Antihistamines
• 3) By Steroids: Oral Steroids; Injectable Steroids
• 4) By Beta-antagonists: Oral Beta-blockers; Injectable Beta-blockers
• 5) By Other Treatments: Corticosteroids; Intravenous Fluids; Other Supportive Treatments
• Companies Mentioned: Merck & Co. Inc.; Novartis International AG; GlaxoSmithKline plc; Viatris Inc.; Teva Pharmaceutical Industries Ltd.; Mylan N.V.; Bausch Health Companies; Sun Pharmaceutical Industries Ltd.; Perrigo Co; Dr. Reddy's Laboratories Ltd.; Hikma Pharmaceuticals plc; Amneal Pharmaceuticals Inc.; ALK-Abello A/S; Amphastar Pharmaceuticals Inc.; Par Pharmaceutical Inc.; Genentech Inc.; Meridian Medical Technologies LLC; Aquestive Therapeutics Inc.; Sandoz Inc.; Adamis Pharmaceutical Corporation; Impax Laboratories LLC
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Anaphylaxis Treatment Market Characteristics

3. Anaphylaxis Treatment Market Trends And Strategies

4. Anaphylaxis Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

• 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Anaphylaxis Treatment Growth Analysis And Strategic Analysis Framework

• 5.1. Global Anaphylaxis Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Anaphylaxis Treatment Market Growth Rate Analysis
• 5.4. Global Anaphylaxis Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Anaphylaxis Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Anaphylaxis Treatment Total Addressable Market (TAM)

6. Anaphylaxis Treatment Market Segmentation

• 6.1. Global Anaphylaxis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Epinephrine
• Antihistamines
• Steroids
• Beta-antagonists
• Other Treatments
• 6.2. Global Anaphylaxis Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Tablets
• Capsules
• Other Products
• 6.3. Global Anaphylaxis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy
• 6.4. Global Anaphylaxis Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Food Allergy
• Pollen Allergy
• Dust Mites Allergy
• Other Applications
• 6.5. Global Anaphylaxis Treatment Market, Sub-Segmentation Of Epinephrine, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Auto-Injectors
• Vials Or Syringes
• 6.6. Global Anaphylaxis Treatment Market, Sub-Segmentation Of Antihistamines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral Antihistamines
• Injectable Antihistamines
• 6.7. Global Anaphylaxis Treatment Market, Sub-Segmentation Of Steroids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral Steroids
• Injectable Steroids
• 6.8. Global Anaphylaxis Treatment Market, Sub-Segmentation Of Beta-antagonists, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral Beta-blockers
• Injectable Beta-blockers
• 6.9. Global Anaphylaxis Treatment Market, Sub-Segmentation Of Other Treatments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Corticosteroids
• Intravenous Fluids
• Other Supportive Treatments

7. Anaphylaxis Treatment Market Regional And Country Analysis

• 7.1. Global Anaphylaxis Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Anaphylaxis Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Anaphylaxis Treatment Market

• 8.1. Asia-Pacific Anaphylaxis Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Anaphylaxis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Anaphylaxis Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Anaphylaxis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Anaphylaxis Treatment Market

• 9.1. China Anaphylaxis Treatment Market Overview
• 9.2. China Anaphylaxis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Anaphylaxis Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Anaphylaxis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Anaphylaxis Treatment Market

• 10.1. India Anaphylaxis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Anaphylaxis Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Anaphylaxis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Anaphylaxis Treatment Market

• 11.1. Japan Anaphylaxis Treatment Market Overview
• 11.2. Japan Anaphylaxis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Anaphylaxis Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Anaphylaxis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Anaphylaxis Treatment Market

• 12.1. Australia Anaphylaxis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Anaphylaxis Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Anaphylaxis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Anaphylaxis Treatment Market

• 13.1. Indonesia Anaphylaxis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Anaphylaxis Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Anaphylaxis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Anaphylaxis Treatment Market

• 14.1. South Korea Anaphylaxis Treatment Market Overview
• 14.2. South Korea Anaphylaxis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Anaphylaxis Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Anaphylaxis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Anaphylaxis Treatment Market

• 15.1. Western Europe Anaphylaxis Treatment Market Overview
• 15.2. Western Europe Anaphylaxis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Anaphylaxis Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Anaphylaxis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Anaphylaxis Treatment Market

• 16.1. UK Anaphylaxis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Anaphylaxis Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Anaphylaxis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Anaphylaxis Treatment Market

• 17.1. Germany Anaphylaxis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Anaphylaxis Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Anaphylaxis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Anaphylaxis Treatment Market

• 18.1. France Anaphylaxis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Anaphylaxis Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Anaphylaxis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Anaphylaxis Treatment Market

• 19.1. Italy Anaphylaxis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Anaphylaxis Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Anaphylaxis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Anaphylaxis Treatment Market

• 20.1. Spain Anaphylaxis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Anaphylaxis Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Anaphylaxis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Anaphylaxis Treatment Market

• 21.1. Eastern Europe Anaphylaxis Treatment Market Overview
• 21.2. Eastern Europe Anaphylaxis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Anaphylaxis Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Anaphylaxis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Anaphylaxis Treatment Market

• 22.1. Russia Anaphylaxis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Anaphylaxis Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Anaphylaxis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Anaphylaxis Treatment Market

• 23.1. North America Anaphylaxis Treatment Market Overview
• 23.2. North America Anaphylaxis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Anaphylaxis Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Anaphylaxis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Anaphylaxis Treatment Market

• 24.1. USA Anaphylaxis Treatment Market Overview
• 24.2. USA Anaphylaxis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Anaphylaxis Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Anaphylaxis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Anaphylaxis Treatment Market

• 25.1. Canada Anaphylaxis Treatment Market Overview
• 25.2. Canada Anaphylaxis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Anaphylaxis Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Anaphylaxis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Anaphylaxis Treatment Market

• 26.1. South America Anaphylaxis Treatment Market Overview
• 26.2. South America Anaphylaxis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Anaphylaxis Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Anaphylaxis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Anaphylaxis Treatment Market

• 27.1. Brazil Anaphylaxis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Anaphylaxis Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Anaphylaxis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Anaphylaxis Treatment Market

• 28.1. Middle East Anaphylaxis Treatment Market Overview
• 28.2. Middle East Anaphylaxis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Anaphylaxis Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Anaphylaxis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Anaphylaxis Treatment Market

• 29.1. Africa Anaphylaxis Treatment Market Overview
• 29.2. Africa Anaphylaxis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Anaphylaxis Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Anaphylaxis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Anaphylaxis Treatment Market Competitive Landscape And Company Profiles

• 30.1. Anaphylaxis Treatment Market Competitive Landscape
• 30.2. Anaphylaxis Treatment Market Company Profiles
  • 30.2.1. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Novartis International AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. GlaxoSmithKline plc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Viatris Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Teva Pharmaceutical Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis

31. Anaphylaxis Treatment Market Other Major And Innovative Companies

• 31.1. Mylan N.V.
• 31.2. Bausch Health Companies
• 31.3. Sun Pharmaceutical Industries Ltd.
• 31.4. Perrigo Co
• 31.5. Dr. Reddy's Laboratories Ltd.
• 31.6. Hikma Pharmaceuticals plc
• 31.7. Amneal Pharmaceuticals Inc.
• 31.8. ALK-Abello A/S
• 31.9. Amphastar Pharmaceuticals Inc.
• 31.10. Par Pharmaceutical Inc.
• 31.11. Genentech Inc.
• 31.12. Meridian Medical Technologies LLC
• 31.13. Aquestive Therapeutics Inc.
• 31.14. Sandoz Inc.
• 31.15. Adamis Pharmaceutical Corporation

32. Global Anaphylaxis Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Anaphylaxis Treatment Market

34. Recent Developments In The Anaphylaxis Treatment Market

35. Anaphylaxis Treatment Market High Potential Countries, Segments and Strategies

• 35.1 Anaphylaxis Treatment Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Anaphylaxis Treatment Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Anaphylaxis Treatment Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer